Price
$2.01
Increased by +4.69%
Dollar Volume
292.02 K
ADR%
11.82
Market Cap.
156.60 M
Shares Float
36.97 M
Shares Outstanding
77.91 M
Beta
0.00
Price / Earnings
0.00
BPR
3.36
20D Range
1.04 2.15
50D Range
0.85 2.15
200D Range
0.85 37.58
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 10, 22 0.76 -0.25
Increased by +404.00%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 82.00 K
Increased by +N/A%
53.24 M
Increased by +37.23 M%
Increased by +64.92 K%
Decreased by N/A%
Jun 30, 22 0.00 - -1.73 M -
Decreased by N/A%
-
Mar 31, 22 0.00 - -4.18 M -
Decreased by N/A%
-
Sep 30, 21 0.00 - -260.31 K -
Decreased by N/A%
-
Jun 30, 21 0.00 - -143.00 -
Decreased by N/A%
-
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.